Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Pediatr. Mar 9, 2022; 11(2): 151-159
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.151
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.151
Barriers and challenges affecting parents’ use of adrenaline auto-injector in children with anaphylaxis
Hassib Narchi, Ahmed Elghoudi, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates
Ahmed Elghoudi, Department of Pediatrics, Sheikh Khalifa Medical City, Abu Dhabi 51900, United Arab Emirates
Ahmed Elghoudi, Child Health Institute, Al Ain Hospital, Al Ain 1006, United Arab Emirates
Klithem Al Dhaheri, Department of Pediatric, Tawam Hospital, Al Ain 15258, United Arab Emirates
Author contributions: Elghoudi A designed the research protocol, sought ethical approval, collected the data, and was involved in writing the manuscript; Narchi H conducted the statistical analyses, constructed the tables and the graph, and participated in writing the manuscript; Dhaheri KA participated in data collection and writing the manuscript; all authors read and approved the final manuscript.
Institutional review board statement: The study was reviewed and approved by Al Ain Hospital Ethical Research Committee Review board (reference number AAHHEC-01-20-001).
Institutional animal care and use committee statement: No animals were involved in the study.
Informed consent statement: Signed informed consent was obtained from all parents who participated in the study.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest to disclose.
Data sharing statement: The anonymised data can be obtained from the principal investigator (ahmed.elghoudi1@gmail.com) upon reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ahmed Elghoudi, MBB Ch, MSc, Doctor, Department of Pediatric, Sheikh Khalifa Medical City, Al Karama Street, Abu Dhabi 51900, United Arab Emirates. ahmed.elghoudi1@gmail.com
Received: April 13, 2021
Peer-review started: April 13, 2021
First decision: July 27, 2021
Revised: August 2, 2021
Accepted: January 19, 2022
Article in press: January 19, 2022
Published online: March 9, 2022
Processing time: 329 Days and 14.2 Hours
Peer-review started: April 13, 2021
First decision: July 27, 2021
Revised: August 2, 2021
Accepted: January 19, 2022
Article in press: January 19, 2022
Published online: March 9, 2022
Processing time: 329 Days and 14.2 Hours
Core Tip
Core Tip: This is a retrospective study evaluating parents’ knowledge of the indications and use of adrenaline auto-injectors in children with anaphylaxis. The state of mind of parents towards the use of the device during anaphylactic episodes in terms of stress, anxiety, comfort, and confidence with the use of the adrenaline auto-injector (AAI) were also evaluated. The study concluded that training and education on how to use the AAI are important, but the psychological status of these parents should not be overlooked, and that sufficient psychological support should be provided in order to assist them to overcome stress and anxiety.